Myotonia Congenita (Non-inflammatory Hereditary Muscle Disease) in Dogs

  • Occurrence: very rare
  • Location of illness: General/Whole body, Head/Neck
Author: Dr. med. vet. Gisa Löwe | Last modified: 06.11.2025

Myotonia congenita is a hereditary muscle disease in dogs characterized by impaired muscle relaxation after contraction. This leads to muscle stiffness, which is particularly noticeable after periods of rest or with sudden movements.

The most important facts at a glance

Myotonia congenita in dogs is a genetically determined muscle disease caused by mutations in genes that affect the function of chloride channels in the muscle cells. These channels are crucial for the relaxation of the muscles after a contraction. The disease is usually inherited in an autosomal recessive manner, meaning that a dog must inherit the mutated gene from both parents to be affected. The disease leads to muscle stiffness and difficulties with movements such as lying down and getting up. Other symptoms include changes in the voice, swallowing disorders, and a stiff gait. Clinical examinations, genetic tests, and electromyographic examinations are used for diagnosis, which can reveal the abnormal electrical activity in the muscles. Treatment focuses on relieving the symptoms, as there is no cure. Medications such as mexiletine can help reduce muscle stiffness, while regular exercise and physiotherapy support muscle strength and mobility. The prognosis varies depending on the severity of the symptoms, but with appropriate care, many affected dogs can lead a relatively normal life. For prevention, genetic selection is important to prevent the transmission of the mutations. Breeders should use genetic tests to identify carriers and exclude them from breeding. Current research focuses on the development of new diagnostic and treatment methods, including the investigation of gene therapy and new drugs. Alternative therapies such as physiotherapy could also contribute to improving the quality of life.

Causes

Myotonia congenita in dogs is a genetic condition caused by mutations in specific genes responsible for the function of ion channels in the muscle membranes. These ion channels, especially the chloride channels, play a crucial role in regulating muscle contraction and relaxation. In myotonia congenita, the chloride channels are impaired in their function, which affects the electrical stability of the muscle cells.

The genetic basis of this disease is often due to an autosomal recessive inheritance, meaning that a dog must inherit the mutated gene from both parents to develop the disease. An autosomal dominant form can also occur, but is rarer.

The mutation leads to a reduced ability of the muscle cells to return to their relaxed state after a contraction. This results in the characteristic muscle stiffness observed in affected dogs. The disruption of the chloride channels leads to increased excitability of the muscle fibers, which causes the symptoms of myotonia.

Symptoms

Affected dogs often show pronounced muscle stiffness, which is particularly noticeable with sudden movements or after periods of rest. After a period of rest, it may take some time for the dog to move normally. This stiffness can be particularly visible in the hind legs, leading to a stiff, halting gait.

Another common symptom is the “goat-like” hopping, in which the dogs walk in a jerky, stiff movement pattern. This behavior is caused by the inability of the muscles to relax quickly enough.

In some cases, dogs may also have Difficulty walking or climbing stairs. Muscle stiffness can improve with heat, while cold often worsens the symptoms.

Diagnosis

The diagnosis of myotonia congenita is based on a combination of clinical symptoms, genetic tests, and electromyographic examinations (EMG). The veterinarian will first perform a thorough clinical examination, observing the characteristic symptoms of muscle stiffness and abnormal gait.

An EMG is an important diagnostic tool because it can reveal the abnormal electrical activity in the muscles that is typical of myotonia. This examination measures the electrical activity of the muscles and can show the characteristic repetitive discharges that occur with this disease.

Genetic tests are also crucial to identify the specific mutation responsible for the myotonia. These tests can help confirm the disease and identify affected dogs as carriers.

Therapy

The treatment of myotonia congenita focuses primarily on symptom control, as there is no cure for the genetic disease. One of the most important treatment strategies is to adapt the dog’s environment and lifestyle to minimize stress and sudden movements that could worsen the symptoms.

Medications such as mexiletine, a sodium channel blocker, can be used to relieve symptoms. Mexiletine helps to stabilize electrical activity in the muscles and reduce muscle stiffness. It is important that the dosage is carefully monitored to avoid side effects.

Regular exercise and physiotherapy can also be helpful to maintain muscle strength and improve mobility. Gentle exercises and stretches can alleviate symptoms and improve the dog’s general well-being.

Prognosis and follow-up care

The prognosis for dogs with myotonia congenita varies depending on the severity of the symptoms and the effectiveness of the treatment. In many cases, affected dogs who are treated and cared for appropriately can lead a relatively normal life.

Quality of life can be improved by adjusting lifestyle and symptomatic treatment. However, some dogs may have more difficulties in everyday life due to the disease, especially if the symptoms are severe or the treatment is not effective.

It is important that owners of affected dogs work closely with their veterinarian to develop an individual treatment plan tailored to their dog’s needs.

Prevention

Since myotonia congenita is a genetic disease, the main focus of prevention is on genetic selection. Breeders should use genetic tests to identify dogs that are carriers of the mutation and exclude these dogs from breeding to prevent the transmission of the mutated gene.

Responsible breeding practices can significantly reduce the risk of affected puppies being born. Educating breeders and dog owners about the genetic aspects of the disease is crucial to reduce the prevalence of myotonia congenita in certain dog breeds.

For dog owners who are interested in a puppy, it is advisable to inquire about the genetic tests and the medical history of the parents. A responsible breeder will be willing to provide this information to ensure that the puppies have the best possible genetic heritage.

Outlook on current research

Research on myotonia congenita in dogs focuses on understanding the genetic basis of the disease and developing better diagnostic and treatment methods. Myotonia congenita is a genetic disorder caused by mutations in the genes responsible for the function of chloride channels in muscle cells. These channels are crucial for the relaxation of muscles after a contraction. In affected dogs, the mutations lead to a delay in muscle relaxation, which causes the characteristic stiffness symptoms.

A significant advance in research has been the identification of specific genetic mutations that cause myotonia congenita in various dog breeds. These genetic markers enable improved genetic testing, which is of great benefit to both breeders and veterinarians. By identifying carriers of these mutations, breeders can develop targeted breeding programs to reduce the spread of the disease within certain breeds.

Current studies are also investigating the possibility of treating the disease through gene therapy approaches. However, this research is still in its early stages. The idea behind gene therapy is to correct or replace the defective genes to restore the normal function of the chloride channels. Although this sounds promising, there are still many hurdles to overcome before such treatments become generally available for dogs.

Another area of research is the development of new drugs that could alleviate the symptoms of myotonia congenita in dogs. Current treatments focus primarily on relieving symptoms through the use of drugs that promote muscle relaxation. Researchers are working to identify new agents that could act more specifically and effectively.

In addition to pharmaceutical research, there are efforts to explore alternative therapies, such as physiotherapy and special training programs, that can help improve muscle control and mobility in affected dogs. These non-invasive methods could be a valuable addition to drug treatments and improve the quality of life for dogs with myotonia congenita.

Frequently asked questions (FAQs)

  1. What is myotonia congenita in dogs? Myotonia congenita is a genetic disease caused by an abnormal function of the muscle cells. It leads to delayed muscle relaxation, which manifests as a characteristic muscle stiffness. The disease is non-inflammatory and is inherited from parents to offspring.

  2. Which dog breeds are most commonly affected? Myotonia congenita can occur in various dog breeds, but some breeds such as the Miniature Schnauzer and the Chow Chow are more commonly affected. However, there are also cases in other breeds and mixed breeds.

  3. How is myotonia congenita diagnosed? The diagnosis is usually based on a combination of clinical symptoms, an electromyographic examination (EMG), and genetic tests. The EMG test measures the electrical activity of the muscles and can identify specific patterns that indicate myotonia congenita. Genetic tests can help identify the specific mutation.

  4. What symptoms does a dog with myotonia congenita show? Typical symptoms are muscle stiffness, which is particularly pronounced after getting up or after periods of rest, Difficulty walking or climbing stairs, and occasional Stumbling. The symptoms can vary depending on the severity of the disease.

  5. How is myotonia congenita treated? Treatment focuses primarily on relieving the symptoms. Medications that promote muscle relaxation can be used. In some cases, physiotherapeutic measures can also be helpful to improve mobility and reduce muscle tension.

  6. Is myotonia congenita curable? Currently, there is no cure for myotonia congenita. Treatment aims to manage the symptoms and improve the dog’s quality of life. However, research in the areas of gene and drug therapy offers hope for future advances.

  7. Can affected dogs lead a normal life? With the right care and treatment, many dogs with myotonia congenita can lead a relatively normal life. However, the symptoms can vary, and in severe cases, the quality of life can be impaired if the disease is not treated appropriately.

  8. How can breeders reduce the risk of myotonia congenita in their breeding? Breeders can use genetic tests to identify carriers of the disease and develop selective breeding strategies to reduce the spread of the disease within the population. By excluding carriers from breeding, the risk of future cases can be reduced.

  9. Are there preventive measures that dog owners can take? The best preventive measure is to select a responsible breeder who pays attention to genetic tests. For dogs already affected, it is important to carry out regular veterinary examinations and follow the veterinarian’s instructions for care and treatment.

  10. What current research results offer hope for the future? Current research focuses on genetic and pharmacological approaches to the treatment of myotonia congenita. In particular, the development of gene therapies and new drugs could offer improved treatment options in the future and significantly improve the quality of life of affected dogs.

Content
Download/Print